Vir Biotechnology, Inc.’s Post

🚀 New Blog Series: Complexity Spectrum in Clinical Trials. We’re excited to kick off a three-part series with our latest blog post, exploring the 'Complexity Spectrum' in clinical trials. Part One dives into a low-complexity prostate cancer trial, highlighting how configurable and flexible approaches are tailored to optimize trial execution. Stay tuned as we continue this series, showcasing strategies for tackling medium and high-complexity trials, ultimately driving the development of more effective therapies 𝗥𝗲𝗮𝗱 𝗣𝗮𝗿𝘁 𝗢𝗻𝗲 𝗵𝗲𝗿𝗲: https://bit.ly/4csHYP1 #ClinicalTrials #HealthcareInnovation #PrecisionMedicine #ProstateCancer #Pharma #Biotech #Oncology #4GClinical

Curious about integrating multi-omics analysis into your drug discovery workflows, but not quite sure where to start? Pluto's scientists are headed to #AACR24 next week to connect with, and learn from, the mission-driven companies pioneering new therapeutics for cancer. We believe in empowering every biologist in biopharma with intuitive ways to make discoveries from their data, and that mission starts with the science. Let's talk about how to use multi-omics analysis to make a real impact on drug discovery timelines: https://lnkd.in/gHpz9r2X #AACR #oncology #bioinformatics #drugdiscovery #cancerresearch

We can’t wait to see some of you this spring at the super chic hotel, The Alexander, in Indianapolis for 🚀 Propel Launch Summit 🚀 May 20-22, 2024. It’ll be here before we know it! Today we were at the event site making preparations for what is sure to be an unforgettable learning and networking event for biopharma leaders launching a product in the next few years. Haven’t saved your seat yet? Go to propellaunch.com before it’s too late! #biopharma #marketaccess #patientaccess #druglaunch #oncology #raredisease #cellandgenetherapy #celltherapy #genetherapy #complexconditions #rarediseases #launchsuccess #pharmalaunch #biopharmalaunch #propellaunch #propellaunchsummit

🔬 For over 20 years, we've been transforming drug development with cutting-edge mathematics and expertise in cancer research. Specialising in sophisticated modelling, we accelerate the complex stages of drug development from pre-clinical to clinical phases. With over 100 projects completed, 50+ targets modelled and 75 drugs advanced across various therapeutic areas, our expert team delivers proven results.💡 🦾 Our approach minimises reliance on time-consuming lab work and animal studies, ensuring you get it right the first time. Ready to de-risk your drug development journey? Reach out to our team! https://lnkd.in/eYmCKgmX #Cancer #DrugDevelopment #CancerDrugs #CancerSimulation #CombinationTherapies #QSP #MathematicalModelling #PKPD #MechanisticModelling #Oncology #ClinicalTrials #ResearchandDevelopment #CancerResearch #BioTech #StatisticalModelling #MachineLearning #Pharma #TranslationalModelling #PYC

🧪⏩ For more than 20 years, we’ve been making the #drugdevelopment journey faster, cheaper and more predictable. 💡 We work with partners to solve real-world treatment challenges and excel in combining knowledge of cancer with cutting-edge mathematics to develop sophisticated models that help speed up the complex stages of drug development, from initial pre-clinical stages to the critical clinical phases. 🤝 Our expert team has successfully completed 100+ projects, modelled 50+ targets, and advanced 75+ drugs across various therapeutic areas. Ready to de-risk your drug development journey? Contact us today: https://lnkd.in/eYmCKgmX #Cancer #DrugDevelopment #VirtualTumour #Immunotherapy #CancerDrugs #CancerSimulation #CombinationTherapies #QSP #MathematicalModelling #PKPD #MechanisticModelling #Oncology #ClinicalTrials #ResearchandDevelopment #CancerResearch #BioTech #StatisticalModelling #MachineLearning #Pharma #PYC

⛵️ The Oncology Race in Biotech: Voyage to First Approval ⛵️ Excited to share a fun new infographic! It highlights biotechs nearing their first oncology approval, showcasing their clinical programs and relative timelines. #Oncology #Biotech #ClinicalTrials #oraclelifesciences #cancermpact

Are you considering the BIG move towards better disease models? 🔬 With RASTRUM™, the transition from 2D to 3D cell models is not as big as you think! Discover the benefits and main considerations when using 3D in the tumour microenvironment for the future of phenotypic drug discovery in oncology with our 3D cell models guide. Learn how RASTRUM Platform simplifies complex model generation for seamless downstream applications, download now! https://lnkd.in/gdHjEtxS #cancerresearch #TME #Extracellularmatrix #Drugdiscovery #3dcellmodels

Better disease models with 3D cell models. With theRASTRUM™ platform, the transition from 2D to 3D cell models is not as big as you think! #cancerresearch #tme #3Dcellmodels #RASTRUM

Ever curious about the future of #syntheticlethality and the discovery of novel synthetic lethal targets in #oncology? So are we, and we have some answers! Ryvu Therapeutics is at the forefront with our advanced drug discovery platform, utilizing human primary models and patient-derived samples. This innovative method is revolutionizing identification of synthetic lethal targets within oncogenic pathways. At #AACR24 today, we're excited to share validating data from our approach using a model CRC system to identify KRAS-specific synthetic lethal targets employing patient-derived cells. #syntheticlethality #newtargets #KRAS

Did you miss our webinar yesterday on Effective Reader Monitoring Plans & Variability QC for ADC, IO, CAR-T & Radiopharmaceutical Studies? Our experts define inter- and intra-observer variability, explain the sources of variability across assessments, and more. Watch it now on-demand! https://lnkd.in/gT5CmzEM Featured Speaker: Lin, Chengyu, M.D. Host/Presenter: Gene Kim, PharmD #MERITCRO #YourClinicalEndpointExpert #clinicalresearch #webinar #oncology #immunooncology #oncologyresearch #oncologytrials